Efficacy of N -methyl- D -aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials

Dysfunction of the -methyl- -aspartate glutamate receptor is involved in the putative pathology of schizophrenia. There is growing interest in the potential of -methyl- -aspartate receptor modulators to improve the symptoms of schizophrenia, but the evidence for the use of glutamatergic agents for a...

Full description

Saved in:
Bibliographic Details
Published inJournal of psychopharmacology (Oxford) Vol. 35; no. 3; p. 236
Main Authors Goh, Kah Kheng, Wu, Tzu-Hua, Chen, Chun-Hsin, Lu, Mong-Liang
Format Journal Article
LanguageEnglish
Published United States 01.03.2021
Subjects
Online AccessGet more information

Cover

Loading…